-
Miglustat, sold
under the
brand name
Zavesca among others, is a
medication used to
treat type I
Gaucher disease and
Pompe disease. It was
approved for...
-
Velaglucerase (approved in 2010)
Taliglucerase alfa (Elelyso) (approved in 2012)
Miglustat is a
small molecule,
orally available drug that was
first approved for...
- therapy. Bone
marrow transplant has been
tried for type B. In
January 2009,
miglustat (Zavesca) was
authorized in the
European Union for the
treatment of progressive...
- 1% of patients. No
clinical interaction studies have been conducted.
Miglustat appears to
increase the
clearance of
imiglucerase by 70%,
resulting in...
- alfa, sold
under the
brand name Pombiliti, and used in
combination with
miglustat, is a
medication used for the
treatment of
glycogen storage disease type...
-
Sodium phenylbutyrate A16AX04
Nitisinone A16AX05 Zinc
acetate A16AX06
Miglustat A16AX07
Sapropterin A16AX08
Teduglutide A16AX09
Glycerol phenylbutyrate...
- the
United States in
September 2024. Arimoclomol, in
combination with
miglustat, is
indicated for the
treatment of
neurological symptoms ****ociated with...
-
multiple sclerosis, and migraine. One drug that has been
tried is
Miglustat.
Miglustat is a
glucosylceramide synthase inhibitor,
which inhibits the synthesis...
-
gelatin capsules. Alpha-glucosidase
inhibitor Αlpha-Amylase
Cinnamon Miglustat Voglibose Scott LJ,
Spencer CM (March 2000). "Miglitol: a
review of its...
- a drug
against type 2 diabetes.
Miglustat is an
iminosugar in
which the ring
oxygen is
replaced by nitrogen.
Miglustat a drug used to
treat some rare lysosomal...
